Dallas Texas Sample Purchase Agreement between Cell Pathways, Inc., MAS Funds Small Cap Value Portfolio, Van Kampen American Value Fund

• Category: Corporations - Public - Purchase
• State: Multi-State
• County: Dallas
• Control #: US-EG-9170
• Format: Word; Rich Text

Description

Purchase Agr. btwn Cell Pathways, Inc., MAS Funds Small Cap Value Portfolio, Van Kampen American Value Fund, et al. dated October 8, 1999. 15 pages. Dallas, Texas is a vibrant and populous city located in the southern United States. Known for its rich history, diverse culture, and thriving economy, Dallas has become a major hub for various industries, including finance, technology, and healthcare. This description will outline the details of a sample purchase agreement specifically designed for the acquisition of Cell Pathways, Inc. by two funds, namely the MAS Funds Small Cap Value Portfolio and the Van Kampen American Value Fund. This Sample Purchase Agreement outlines the terms and conditions agreed upon by all parties involved in the transaction. It serves as a legally binding document that governs the purchase of Cell Pathways, Inc., a biotechnology company based in Dallas, Texas. Key aspects covered in this agreement include the purchase price, payment terms, transaction timeline, representations and warranties, and any specific conditions precedent to the completion of the acquisition. Under this agreement, the MAS Funds Small Cap Value Portfolio and the Van Kampen American Value Fund agree to acquire all the outstanding shares of Cell Pathways, Inc. The purchase price will be determined through a negotiated process, taking into account the company's financial performance, goodwill, and potential growth prospects. The payment terms will be structured to accommodate the interests of both the buyers and the sellers. The agreement may define different methods of payment, such as cash, stock consideration, or a combination of both, depending on the negotiations between the parties. The transaction timeline will outline the various stages of the acquisition process, including due diligence, regulatory approvals, and closing procedures. It will also stipulate any deadlines and milestones that need to be met by both parties. To ensure transparency and protect the interests of all parties, this agreement will contain a section detailing the representations and warranties. These statements will cover pertinent information about the financial condition, legal standing, and operational aspects of Cell Pathways, Inc. It will also address any potential liabilities or contingencies that may impact the transaction. Lastly, the Sample Purchase Agreement may include various conditions precedent that need to be fulfilled for the acquisition to be completed. These conditions may include obtaining necessary regulatory approvals, shareholder consent, or the absence of any material adverse changes in the company's business. In conclusion, this detailed Sample Purchase Agreement provides a framework for the acquisition of Cell Pathways, Inc. by the MAS Funds Small Cap Value Portfolio and the Van Kampen American Value Fund. By aligning the interests of all parties involved, this agreement aims to facilitate a smooth and successful transaction.

Dallas, Texas is a vibrant and populous city located in the southern United States. Known for its rich history, diverse culture, and thriving economy, Dallas has become a major hub for various industries, including finance, technology, and healthcare. This description will outline the details of a sample purchase agreement specifically designed for the acquisition of Cell Pathways, Inc. by two funds, namely the MAS Funds Small Cap Value Portfolio and the Van Kampen American Value Fund. This Sample Purchase Agreement outlines the terms and conditions agreed upon by all parties involved in the transaction. It serves as a legally binding document that governs the purchase of Cell Pathways, Inc., a biotechnology company based in Dallas, Texas. Key aspects covered in this agreement include the purchase price, payment terms, transaction timeline, representations and warranties, and any specific conditions precedent to the completion of the acquisition. Under this agreement, the MAS Funds Small Cap Value Portfolio and the Van Kampen American Value Fund agree to acquire all the outstanding shares of Cell Pathways, Inc. The purchase price will be determined through a negotiated process, taking into account the company's financial performance, goodwill, and potential growth prospects. The payment terms will be structured to accommodate the interests of both the buyers and the sellers. The agreement may define different methods of payment, such as cash, stock consideration, or a combination of both, depending on the negotiations between the parties. The transaction timeline will outline the various stages of the acquisition process, including due diligence, regulatory approvals, and closing procedures. It will also stipulate any deadlines and milestones that need to be met by both parties. To ensure transparency and protect the interests of all parties, this agreement will contain a section detailing the representations and warranties. These statements will cover pertinent information about the financial condition, legal standing, and operational aspects of Cell Pathways, Inc. It will also address any potential liabilities or contingencies that may impact the transaction. Lastly, the Sample Purchase Agreement may include various conditions precedent that need to be fulfilled for the acquisition to be completed. These conditions may include obtaining necessary regulatory approvals, shareholder consent, or the absence of any material adverse changes in the company's business. In conclusion, this detailed Sample Purchase Agreement provides a framework for the acquisition of Cell Pathways, Inc. by the MAS Funds Small Cap Value Portfolio and the Van Kampen American Value Fund. By aligning the interests of all parties involved, this agreement aims to facilitate a smooth and successful transaction.